Pre-Announcement/Annonce Préalable/Vorankündigung

July 17, 2003 10:51 ET | Source: Novartis Pharma AG Novartis Pharma AG

Please see full press release under the following link:

Attachments

Novartis Release

Novartis Release...

Recommended Reading

July 31, 2026 16:25 ET | Source: Novartis Pharma AG

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient populationPSMAddition updated results show Pluvicto reduced risk of progression or death by 33% in...
Read More
July 21, 2026 01:00 ET | Source: Novartis Pharma AG

Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed

Ad hoc announcement pursuant to Art. 53 LRSecond quarterNet sales grew +1% (cc1, +3% USD), with core operating income1 flat (cc and USD)Sales growth driven by priority brands including Kisqali (+43%...
Read More